Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence

Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence

Abstract Immunotherapy is a class of promising anticancer treatments that has recently gained attention due to surging numbers of FDA approvals and extensive preclinical studies demonstrating efficacy. Nevertheless, further clinical implementation has been limited by high variability in patient resp...

Full description

Bibliographic Details
Main Authors: Xingwu Zhou, Moyuan Qu, Peyton Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Oklu, Shiladitya Sengupta, Wujin Sun, Ali Khademhosseini
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Advanced Science
Subjects:
artificial intelligence
cancer immunotherapy
drug screening
high‐throughput screening
tissue engineering
Online Access:https://doi.org/10.1002/advs.202001447

Internet

https://doi.org/10.1002/advs.202001447

Similar Items